| 1 |
31892214 | Flow-Based Three-Dimensional Co-Culture Model for Long-Term Hepatotoxicity Prediction. | 2019 Dec 27 |
1 |
| 2 |
26094899 | Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes. | 2015 |
1 |
| 3 |
23407222 | The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals. | 2013 Mar |
1 |
| 4 |
18589587 | [Cytochrome P450 and NAT2 polymorphisms and drug metabolism in DOTS]. | 2008 Jan-Feb |
1 |
| 5 |
16669850 | An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid. | 2006 May |
1 |
| 6 |
15546903 | CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. | 2005 Feb |
2 |
| 7 |
16324277 | [The combined effect of isoniazid and rifampicin on the activities of CYP4501A2 and CYP4503A4 in primary hepatocytes from healthy human adults]. | 2005 Nov |
4 |
| 8 |
15005856 | CYP3A4 is a human microsomal vitamin D 25-hydroxylase. | 2004 Apr |
2 |
| 9 |
15304522 | Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro. | 2004 Dec |
2 |
| 10 |
15528841 | Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities. | 2004 Nov |
1 |
| 11 |
11868802 | Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. | 2002 Jan |
6 |
| 12 |
11158730 | Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A. | 2001 Feb |
1 |
| 13 |
9855331 | Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. | 1998 Nov-Dec |
1 |